InvestorsHub Logo
Followers 6
Posts 4111
Boards Moderated 0
Alias Born 12/14/2009

Re: CATTDOGG12347 post# 96714

Tuesday, 04/02/2019 6:50:10 PM

Tuesday, April 02, 2019 6:50:10 PM

Post# of 108191
It's the science that the market is valuing at this point. The market was generous with ADXS giving the company more than $200m on attractive terms with high hopes the trial data would be strong. Beginning in 2017 it became more apparent the combo trial data was not good enough for Astra and Merck to partner, then in late 2018 when Amgen saw the prelim NEO data....game over.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News